Coeptis Therapeutics Holdings, Inc.
Biopharmaceutical company developing cell therapy platforms for cancer and other diseases.
COEP | US
Overview
Corporate Details
- ISIN(s):
- US19207A2078 (+2 more)
- LEI:
- Country:
- United States of America
- Address:
- 105 BRADFORD ROAD, SUITE 420, 15090 WEXFORD
- Website:
- https://coeptistx.com/
- Sector:
- Manufacturing
Description
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company that develops innovative cell therapy platforms. The company's primary focus is on creating treatments for cancer, with additional development programs targeting autoimmune and infectious diseases. Its pipeline includes advanced technologies such as CAR-T cell therapies, aimed at addressing significant unmet medical needs and improving patient outcomes in its target therapeutic areas.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Coeptis Therapeutics Holdings, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Coeptis Therapeutics Holdings, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Coeptis Therapeutics Holdings, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
